2010
DOI: 10.4172/2155-6156.1000104
|View full text |Cite
|
Sign up to set email alerts
|

A Pregnant Patient with Brittle Type 1 Diabetes Successfully Managed by CSII Therapy with Insulin Aspart

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 3 publications
0
5
0
Order By: Relevance
“…In Type-1 Diabetes, the body produces little or no insulin so those with this type of diabetes need to be on insulin therapy for their entire lives [53]. Type-1 diabetes mellitus is characterized by loss of the insulin-producing beta cells of the islets [54] of Langerhans in the pancreas leading to insulin deficiency [55].…”
Section: Type-1 Diabetesmentioning
confidence: 99%
“…In Type-1 Diabetes, the body produces little or no insulin so those with this type of diabetes need to be on insulin therapy for their entire lives [53]. Type-1 diabetes mellitus is characterized by loss of the insulin-producing beta cells of the islets [54] of Langerhans in the pancreas leading to insulin deficiency [55].…”
Section: Type-1 Diabetesmentioning
confidence: 99%
“…Continuous subcutaneous insulin infusion (CSII) therapy is widely accepted for brittle type 1 diabetes, since it has the benefit of less frequency of hypoglycemia and better management of the dawn phenomenon compared to multiple daily insulin injection (MDI) therapy [57]. Comparative studies between African and European populations suggest that total lymphocyte count (TLC), including CD4+ count, is likely to vary significantly by ethnicity, in both, healthy and HIV-infected Individuals [58]. Natural killer (NK) cell function was investigated in Malaysian HIV patients beginning antiretroviral therapy (ART) with advanced immunodeficiency.…”
Section: Gene Therapy and Other Diagnosis Factors In Cure Of Diseasesmentioning
confidence: 99%
“…Women who have had gestational diabetes have a 40 to 60 percent chance of developing type2 diabetes within 5 to 10 years. Type1 diabetes can be managed by various Continuous subcutaneous insulin infusion therapies [19]. Women with the history of gestational diabetes mellitus (GDM) have a significantly increased risk of type 2 diabetes and of cardiovascular disease during the next years after delivery [20].…”
Section: Type 2 Diabetesmentioning
confidence: 99%